Marker Therapeutics

MRKR

NASDAQHealth Care

Income Statement

Total Revenue$6.59M

Gross Profit$6.59M

Operating Income$-11.12M

EBITDA$-10.68M

EBIT$-10.68M

Pre-tax Income$-12.18M

Net Income$-10.73M

Cash Equivalent$11.83M

Total Debt$0

Book Value$11.87M

Book Value Per Share1.33

Return on Equity (ROE)-57.82%

Return on Assets (ROA)-48.73%

Return on Invested Capital (ROI)-57.82%

Net Profit Margin-162.82%

Current Ratio6.36

Quick Ratio6.22

Long-Term Debt / Equity0.00